Global NTM Infections Pipeline Poised for Growth as Breakthrough Therapies Advance Toward Late-Stage Development, states DelveInsight

Prominent Nontuberculous Mycobacterial (NTM) Infections emerging therapies include ALIS, Antimycobacterial regimen, ...
Monthly Prescribing Reference

MannKind Ends Trial of Nebulized Clofazimine for NTM Lung Disease

A phase 3 trial evaluating a nebulized clofazimine inhalation suspension (MNKD-101) for the treatment of refractory nontuberculous mycobacterial (NTM) lung disease has been discontinued. The ...
Medical Xpress

Study reveals how a stubborn lung infection evolves inside patients over years

Researchers at Trinity Translational Medicine Institute (TTMI) and the Irish Mycobacterial Reference Laboratory at St James's Hospital have uncovered how the bacterium Mycobacterium avium—a leading ...
Milwaukee Journal Sentinel

In Treating Measles Infection, NV-387 Showed Strong Antiviral Activity, and Significantly, Protected Lungs from Damage, Describes NanoViricides

SHELTON, CONNECTICUT / ACCESS Newswire / October 22, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the “Company”), announced that its clinical lead drug NV-387 has shown ...
Healio

Patients with rheumatoid arthritis-associated lung disease face higher infection risk

Please provide your email address to receive an email when new articles are posted on . RA-ILD was associated with an increased risk for infection vs. RA without lung disease. RA-associated ...